Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: Patterns of response

Clinical and Experimental Allergy

Volumn 41, Issue 1, 2011, Pages 86-95

  Dona I ^a   Blanca Lopez N ^a,b   Cornejo Garcia J A ^a   Torres, M J ^a   Laguna, J J ^c   Fernandez J ^d   Rosado, A ^e   Rondon C ^a   Campo, P ^a   Agundez J A ^f   Blanca, M ^a   Canto, G ^a,b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^c HOSPITAL CENTRAL DE LA CRUZ ROJA   (Spain)

^d Elche University Hospital   (Spain)

^e HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^f UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Cross intolerance; Drug provocation test; Nasal aspirin provocation test; Non steroidal anti inflammatory drugs; Selective hypersensitivity

Indexed keywords

ACETYLSALICYLIC ACID; ARYLACETIC ACID DERIVATIVE; IBUPROFEN; IMMUNOGLOBULIN E; INDOLEACETIC ACID; NICOTINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PARACETAMOL; PROPIONIC ACID; PROPIONIC ACID DERIVATIVE; PYRAZOLONE DERIVATIVE;

ADULT; AGED; AIRWAY; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; ATOPY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG CROSS TOLERANCE; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; RHINITIS; SKIN; SKIN ALLERGY; SKIN TEST; URTICARIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA, ASPIRIN-INDUCED; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 78650021955     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03651.x     Document Type: Article

References (34)

1. Roberts LJ, Morrow JD. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LL, Goodman Gilman A, eds. The pharmacological basis of therapeutics, 10th edn. New York: McGraw-Hill, 2001; 687-731.
2. Szczeklik A, Nizankowska E, Sanak M. Hypersensitivity to aspirin and non-steroidal antiinflammtory drugs. In: Adkinson NF, Bochner BS, Busse WW, Holgate S, Lemanske RF, Simons FE, eds. Middelton's allergy, principles and practice, 7th edn. Philadelphia: Mosby, 2009; 1227-43.
3. Aberer W, Bircher A, Romano A et al. Drug provocation testing in diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58:854-63.
4. Himly M, Jahn-Schmid B, Pittertschatscher K et al. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol 2003; 111:882-8.
5. Schneider CH, Kasper MF, De Weck AL, Rolli H, Angst BD. Diagnosis of antibody-mediated drug allergy. Pyrazolinone and pyrazolidinedione cross-reactivity relationships. Allergy 1987; 42:597-603.
6. Blanca M, Perez E, Garcia JJ et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy 1989; 62:295-8.
7. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis and management. J Allergy Clin Immunol 2003; 111:913-21.
8. Jenkins C, Costello J, Hodge L. Systemic review of prevalence of aspirin induced asthma and its implications for clinical practice. Br Med J 2004; 328:434-41.
9. Setkowicz M, Mastalerz L, Podolec-Rubis M, Sanak M, Szczeklik A. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years. J Allergy Clin Immunol 2009; 123:174-8.
10. Blanca M, Doña I, Torres MJ et al. Non Steroids Anti-inflammatory Drugs (NSAIDs) intolerance versus allergy: patterns of response and drug involved. J Allergy Clin Immunol 2009; 123:S239.
11. Harrer A, Stöcklinger A, Weiss R, Thalhamer J, Ferreira F, Himly M Diclofenac-specific monoclonal antibodies show variable crossreactivity to diclofenac metabolites. Allergy 2007; 62:S35-S36.
12. Fontaine C, Bousquet PJ, Demoly P. Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole. J Allergy Clin Immunol 2005; 115:633-4.
13. Gómez E, Blanca-Lopez N, Torres MJ et al. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy 2009; 39:1217-24.
14. Posadas SJ, Padial A, Torres MJ et al. Delayed reactions to drugs show a Th1 profile and levels of perforin, granzyme B and Fas-L related to disease severity. J Allergy Clin Immunol 2002; 109:155-61.
15. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57:45-51.
16. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007; 62:1111-8.
17. Rondón C, Romero JJ, López S et al. Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol 2007; 119:899-905.
18. Fosbøl EL, Gislason GH, Jacobsen S et al. The pattern of use of non steroidal antiinflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people. Pharmacoepidemiol Drug Safety 2008; 17:822-33.
19. Manfredi G. Adverse drug reactions prevalence in south Italy. Allergy 2008; 63:S110-S111.
20. Available at (accessed 25 June 2010).
21. Lafrance JP, Miller DR. Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury. Pharmacoepidemiol Drug Saf 2009; 18:923-31.
22. Gislason GH, Rasmussen JN, Abildstrom SZ et al. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med 2009; 169:141-9.
23. Nettis E, Giordano D, Colanardi MC, Paradiso MT, Ferrannini A, Tursi A. Delayed-type hypersensitivity rash from ibuprofen. Allergy 2003; 58:539-40.
24. Rojas-Hijazo B, Garcés MM, Ferrer L, Lezaun A, Colás C. Anaphylactic reaction after aceclofenac intake. Allergy 2006; 61:511.
25. Micheletto C, Visconti M, Tognella S, Facchini FM, Dal Negro RW. Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild topic asthma, and normal controls. Eur Ann Allergy Clin Immunol 2006; 38:20-3.
26. Quiralte J, Blanco C, Castillo R, Delgado J, Carrillo T. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996; 98:678-85.
27. Berkes E. Anaphylactic and anaphylactoid reactions to aspirin and other NSAIDs. Clin Rev Allergy Immunol 2003; 24:137-47.
28. Sánchez-Borges M, Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol 2000; 84:101-6.
29. Asero R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol 2003; 111:1095-8.
30. Bochenek G, Nizankowska E, Szczeklik A. The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 1996; 51:16-23.
31. Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. Strong immediate-type skin test responses to Blomia tropicalis in nonsteroidal anti-infl ammatory drug-sensitive subjects with urticaria and angioedema. Allergy Clin Immunol Int: J World Allergy Org 2007; 19:239-42.
32. Acevedo N, Vergara C, Mercado D, Jimenez S, Caraballo L. The A-444C polymorphism of leukotriene C4 synthase gene is associated with IgE antibodies to Dermatophagoides pteronyssinus in a Colombian population. J Allergy Clin Immunol 2007; 119:505-7.
33. Lamoureux J, Stankova J, Rola-Pleszczynski M. Leukotriene D4 enhances immunoglobulin production in CD40-activated human B lymphocytes. J Allergy Clin Immunol 2006; 117:924-30.
34. Kim DC, Hsu FI, Barrett NA et al. Cysteinyl leukotrienes regulate TH2 cell-dependent pulmonary inflammation. J Immunol 2006; 176:4440-8.